AKZO NOBEL SPONS.ADRS 1/3 (AKUP) - Total Liabilities
Based on the latest financial reports, AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has total liabilities worth €9.13 Billion EUR (≈ $10.67 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AKZO NOBEL SPONS.ADRS 1/3 operating cash flow efficiency to assess how effectively this company generates cash.
AKZO NOBEL SPONS.ADRS 1/3 - Total Liabilities Trend (2022–2025)
This chart illustrates how AKZO NOBEL SPONS.ADRS 1/3's total liabilities have evolved over time, based on quarterly financial data. For the full company profile including market capitalisation, see AKZO NOBEL SPONS.ADRS 1/3 stock valuation.
AKZO NOBEL SPONS.ADRS 1/3 Competitors by Total Liabilities
The table below lists competitors of AKZO NOBEL SPONS.ADRS 1/3 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NMDC Limited
NSE:NMDC
|
India | Rs100.09 Billion |
|
Krka d. d
WAR:KRK
|
Poland | zł662.58 Million |
|
Korea Investment Holdings Co
KO:071050
|
Korea | ₩111.45 Trillion |
|
GMéxico Transportes S.A.B. de C.V
MX:GMXT
|
Mexico | MX$72.07 Billion |
|
ALD SA
PA:AYV
|
France | €59.81 Billion |
|
Moog Inc
NYSE:MOG-A
|
USA | $2.49 Billion |
|
Huadong Medicine Co Ltd
SHE:000963
|
China | CN¥15.43 Billion |
|
Meridian Energy Ltd
AU:MEZ
|
Australia | AU$6.24 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down AKZO NOBEL SPONS.ADRS 1/3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AKZO NOBEL SPONS.ADRS 1/3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
The table below shows the annual total liabilities of AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €9.13 Billion ≈ $10.67 Billion |
-3.21% |
| 2024-12-31 | €9.43 Billion ≈ $11.03 Billion |
-5.78% |
| 2023-12-31 | €10.01 Billion ≈ $11.71 Billion |
-1.78% |
| 2022-12-31 | €10.19 Billion ≈ $11.92 Billion |
-- |
About AKZO NOBEL SPONS.ADRS 1/3
Akzo Nobel N.V. produces and sells paints and coatings worldwide. It operates through Decorative Paints and Performance Coatings segments. The company offers decorative paints, including paints, enamels, varnishes, and surface preparation products; and a range of mixing machines, color concepts and advice, and training for applicators. It also provides performance coatings that produces engineere… Read more